HYDERABAD | MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT - In a regulatory update submitted to the Indian Stock Exchanges, Hyderabad headquartered Dr. Reddy's Laboratories said of having entered in Nutrition segment, where the company launched diabetes nutrition drink 'Celevida', in India.
The press-release as submitted by the company to the Indian Bourses - titled, "Dr. Reddy’s Laboratories enters Nutrition Segment with Celevida in India" further read that, Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY), today announced the entry into the nutrition segment with the launch of its diabetes nutrition drink ‘Celevida’ in India.
It’s a first-of-its-kind under Dr. Reddy’s nutrition portfolio and clinically proven to help manage blood glucose levels among Indian patients.
The brand ‘Celevida’ is derived from two words ‘Celebration’ and ‘Vida’*, which means ‘Celebrate Life’.
It is available in two flavors – Kesar Elachi and Chocolate, which are taste tested with 300+ diabetics and prediabetics.
M V Ramana, Chief Executive Officer, Branded Markets (India and Emerging Markets), Dr. Reddy’s Laboratories said, “We are pleased to mark our foray into the nutrition segment with Celevida, which will address unmet nutrition needs of the patients in India. Through this nutrition drink, we continue to work towards making a positive impact on people’s health and quality of life.”
Dr. Reddy’s Celevida is formulated to have high protein (28-30%), high fiber (12-18%) and slowly digested carbohydrates, which will support in managing the postprandial blood glucose response and satiety.
The product contains high amount of plant protein that comes from Soy, Ragi and Gram flours.
The product has 20 vitamins and minerals, and ingredient such as Folate, Iron, Magnesium, Pantothenic acid, Riboflavin, Vitamin B12, Vitamin B6 and Vitamin C that would further support in managing tiredness and fatigue.
Diabetes is a growing challenge in India with a large diabetic (around 73 million) and pre-diabetes population (around 80 million people) and we are estimated to have world’s largest diabetes population by 2035.
What is contributing to the rise of diabetes in the growing population is the changing habits of diet and a sedentary lifestyle.
The Indian Council of Medical Research has recommended that, the daily diet of an adult should contain at least 60g of protein and 40g of dietary fibre (based on a 2000 Kcal diet).
About Dr. Reddy’s : Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) is an integrated pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives.
Through its three businesses - Pharmaceutical Services & Active Ingredients, Global Generics and Proprietary Products – Dr. Reddy’s offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, biosimilars and differentiated formulations.
Our major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology.
Dr. Reddy’s operates in markets across the globe.
Our major markets include – USA, India, Russia & CIS countries, and Europe. For more information, log on to: www.drreddys.com
FOLLOW US ON :-
- BLOG : http://datelinegujarat.blogspot.com/
- FACEBOOK : https://facebook.com/dateline.gujarat
- GOOGLE+ : https://plus.google.com/110800330482982580799
- INSTAGRAM : https://www.instagram.com/datelinegujarat/
- LINKEDIN : https://in.linkedin.com/in/dateline-gujarat-7681885a
- TELEGRAM : https://t.me/DATELINEGUJARATDOTCOM
- TWITTER : https://twitter.com/DatelineGujarat
- YOUTUBE : https://www.youtube.com/user/DatelineGujarat
- WEBSITE (URL) : https://datelinegujarat.com/
No comments:
Post a Comment